Case Report
The Journal of the Korean Rheumatism Association 2007; 14(4): 401-406
Published online December 30, 2007
© Korean College of Rheumatology
피부근염 환자에서 빠르게 진행한 간질성폐렴 1예
윤재영ㆍ민선양ㆍ박주이ㆍ홍승권ㆍ강효종
분당제생병원 내과
Rapidly Progressive Interstitial Lung Disease Associated with Dermatomyositis; A Case Report
Correspondence to : Hyo Jong Kang
A previously healthy 44-year-old woman who was diagnosed as having dermatomyositis suddenly developed severe dyspnea while being in the state of improved condition of muscle weakness. Interstitial lung disease was found on high resolution computed tomography (HRCT). In spite of the treatment with the immune-modulating agent (high dose steroid, cyclophosphamide, immunoglubulin and cyclosporine), her condition deteriorated further and rapidly, leading to death. More intensive agent such as FK506 would be necessary in those cases of dermatomyositis-related interstitial lung disease that have poor prognostic factors.
Keywords Interstitial lung disease, Dermatomyositis
PDF
Standard view
Export citation
Share Article
Case Report
The Journal of the Korean Rheumatism Association 2007; 14(4): 401-406
Published online December 30, 2007
Copyright © Korean College of Rheumatology.
피부근염 환자에서 빠르게 진행한 간질성폐렴 1예
윤재영ㆍ민선양ㆍ박주이ㆍ홍승권ㆍ강효종
분당제생병원 내과
Rapidly Progressive Interstitial Lung Disease Associated with Dermatomyositis; A Case Report
Jae Young Yoon, M.D., Sun Yang Min, M.D., Ju Yee Park, M.D., Seung Goun Hong, M.D., Hyo Jong Kang, M.D.
Department of Internal Medicine, Bundang Jesaeng General Hospital, Seongnam, Korea
Correspondence to:Hyo Jong Kang
Abstract
A previously healthy 44-year-old woman who was diagnosed as having dermatomyositis suddenly developed severe dyspnea while being in the state of improved condition of muscle weakness. Interstitial lung disease was found on high resolution computed tomography (HRCT). In spite of the treatment with the immune-modulating agent (high dose steroid, cyclophosphamide, immunoglubulin and cyclosporine), her condition deteriorated further and rapidly, leading to death. More intensive agent such as FK506 would be necessary in those cases of dermatomyositis-related interstitial lung disease that have poor prognostic factors.
Keywords: Interstitial lung disease, Dermatomyositis
Article Tools
Stats or Metrics
Share this article on
Related articles in JRD
-
Clinical Characteristics of the Lung Involvement in Korean Patients with Inflammatory Myositis
Hyun-Sook Kim, M.D., Soo-Hong Seo, M.D., Ji-An Hur, M.D.*, Seung-Ki Kwok, M.D., Ji Hyeon Ju, M.D., Chong-Hyeon Yoon, M.D., Wan-Uk Kim, M.D., Yeon-Sik Hong, M.D., Chul-Soo Cho, M.D., Ho-Youn Kim, M.D., Sung-Hwan Park, M.D.
The Journal of the Korean Rheumatism Association 2007; 14(1): 15-22 -
Unraveling the diagnostic odyssey: stimulator of interferon gene-associated vasculopathy with onset in infancy in a 30-year-old female
Hae Ryung Kim, M.D., Seon Hee Lim, M.D., Ji Soo Park, M.D., Dong In Suh, M.D., Ph.D., Seungbok Lee, M.D., Soo Yeon Kim, M.D., Jong Hee Chae, M.D., Ph.D., Seong Heon Kim, M.D.
J Rheum Dis 2024; 31(3): 182-187 -
Radiologic approach and progressive exploration of connective tissue disease-related interstitial lung disease: meeting the curiosity of rheumatologists
Hyeji Jeon, M.D., Bo Da Nam, M.D., Chong-Hyeon Yoon, M.D, Ph.D., Hyun-Sook Kim, M.D, Ph.D.
J Rheum Dis 2024; 31(1): 3-14
